EC is characterized by elevated expression of multiple Wnt ligands (notably Wnt2, Wnt3, Wnt5A, and Wnt6) and FZD receptors, often correlating with poorer differentiation, higher potential of tumor invasion, and shorter survival. Here, WNT5A is linked to neoplasm.